文献速递前列腺增生与排尿功能障碍

尿道成形术围手术期实践模式:泌尿生殖重建外科医生调查

Determining Perioperative Practice Patterns in Urethroplasty: A Survey of Genitourinary Reconstructive Surgeons.
PubMed 文献 · Urology · 2021-06-26

该研究于2019年8-10月对GURS成员进行在线调查,评估前尿道成形术围手术期管理,应答率57.2%(142/248)。多数医生每年完成>20例尿道成形术(76.1%),几乎所有医生术中静脉使用抗生素(97.9%)。在抗生素使用、VTE预防、供区管理、导管管理和随访评估方面仍存在异质性。

要点

  • 多数GURS成员每年完成>20例尿道成形术,术中静脉抗生素使用率达97.9%。
  • 仅40.1%医生术中行药物性血栓预防,53.5%供区开放,21.8%处方卧床休息。
  • 术后70.4%常规口服抗生素,58.5%留置尿道导管2-3周,67.6%拔管时行尿道造影。

核心结论

  • 尽管尿道成形术管理选项存在普遍共识,但在抗生素使用、VTE预防、供区管理、导管管理和随访评估方面仍存在异质性。

研究设计与样本

  • 2019年8-10月对248名GURS成员进行在线问卷调查,应答率57.2%(n=142)。

主要发现

  • 76.1%(108/142)的参与者每年完成>20例尿道成形术。
  • 97.9%(139/142)术中静脉使用抗生素,40.1%(57/142)术中行药物性血栓预防。
  • 97.2%(138/142)偏好颊黏膜移植,53.5%(76/142)供区开放。
  • 21.8%(31/142)处方卧床休息,25.4%(36/142)常规放置引流。
  • 70.4%(100/142)术后常规口服抗生素,其中72.2%(70/97)持续至拔除尿管。

关键数值与推荐

  • 67.6%(96/142)拔管时常规行尿道造影,78.2%(111/142)偏好客观检查如尿流率(82.0%)和残余尿(79.3%)。
  • 57.7%(64/111)行膀胱镜检查,44.2%(49/111)术后2-3月常规检查,34.2%(38/111)术后4-6月检查。

临床怎么用

  • 调查结果提示尿道成形术围手术期管理存在较大差异,临床可参考多数做法但需结合个体化评估。

局限性

  • 调查仅纳入GURS成员,应答率57.2%,结果可能不能推广至所有泌尿外科医生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To better delineate perioperative urethroplasty practice patterns among reconstructive urologists given that management strategies in reconstructive urology have generally been poorly described. METHODS: An online survey examining perioperative management of anterior urethroplasty patients was administered to Society of Genitourinary Reconstructive Surgeons (GURS) members between August-October 2019. Questions pertained to tissue transfer, pharmacologic prophylaxis, catheter use, follow-up, and post-operative care. RESULTS: A total of 248 GURS members were invited to participate, with a response rate of 57.2% (n = 142). Most participants performed >20 urethroplasties per year (n = 108, 76.1%). Almost all respondents (97.9%, n = 139) used intraoperative intravenous antibiotics. A minority of surgeons used intraoperative pharmacologic thromboembolism prophylaxis (n = 57, 40.1%). Surgeons prefer buccal mucosa for grafting (n = 138, 97.2%) with many leaving the donor site open (n = 76, 53.5%). Only 21.8% (n = 31) of surgeons prescribe bedrest for patients and 25.4% (n = 36) routinely place drains. Postoperatively, oral antimicrobials are routinely administered (n=100, 70.4%), with most continuing until the urinary catheter is removed (70, 72.2%). Patients commonly had a urethral catheter for 2-3 (n = 72, 58.5%) or 3-4 weeks (n = 37, 30.1%). At catheter removal, surgeons routinely perform urethral imaging with contrast (n=96, 67.6%). Most surgeons prefer some form of objective investigation (n = 111, 78.2%) (uroflowmetry [n = 91, 82.0%], post-void residual [n = 88, 79.3%]). Cystoscopy is also commonly performed (n = 64, 57.7%). These investigations are routinely performed at 2-3 (n = 49, 44.2%) or 4-6 months (n = 38, 34.2%) postoperatively. CONCLUSION: Despite general consensus on urethroplasty management options, heterogeneity remains in the areas of antibiotic use, VTE prophylaxis, donor site management, catheter management, and follow-up assessment.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Hoare DT, Doiron RC, Rourke KF, et al. Determining Perioperative Practice Patterns in Urethroplasty: A Survey of Genitourinary Reconstructive Surgeons. Urology. 2021. PMID: 34186137. doi:10.1016/j.urology.2021.05.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。